These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23664229)

  • 1. The failure of biologics in sepsis: where do we stand?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S45-7. PubMed ID: 23664229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging drugs for the treatment of sepsis.
    Kotsaki A; Giamarellos-Bourboulis EJ
    Expert Opin Emerg Drugs; 2012 Sep; 17(3):379-91. PubMed ID: 22780561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial.
    Hentrich M; Fehnle K; Ostermann H; Kienast J; Cornely O; Salat C; Ubelacker R; Buchheidt D; Behre G; Hiddemann W; Schiel X
    Crit Care Med; 2006 May; 34(5):1319-25. PubMed ID: 16540956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous polyclonal IgM-enriched immunoglobulin therapy in sepsis: a review of clinical efficacy in relation to microbiological aetiology and severity of sepsis.
    Norrby-Teglund A; Haque KN; Hammarström L
    J Intern Med; 2006 Dec; 260(6):509-16. PubMed ID: 17116001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?
    Di Rosa R; Pietrosanti M; Luzi G; Salemi S; D'Amelio R
    Eur J Intern Med; 2014 Jul; 25(6):511-6. PubMed ID: 24877856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis.
    Laupland KB; Kirkpatrick AW; Delaney A
    Crit Care Med; 2007 Dec; 35(12):2686-92. PubMed ID: 18074465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness analysis of polymyxin-B immobilized fiber column and conventional medical therapy in the management of abdominal septic shock in Italy.
    Berto P; Ronco C; Cruz D; Melotti RM; Antonelli M
    Blood Purif; 2011; 32(4):331-40. PubMed ID: 22086346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of IgM and IgA-enriched immunoglobulins in the treatment of severe sepsis and septic shock. Clinical experience.
    Berlot G; Dimastromatteo G
    Minerva Anestesiol; 2004 Oct; 70(10):739-43; 743-5. PubMed ID: 15516885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mediator-specific therapies for the systemic inflammatory response syndrome, sepsis, severe sepsis, and septic shock: present and future approaches.
    Hazinski MF
    Crit Care Nurs Clin North Am; 1994 Jun; 6(2):309-19. PubMed ID: 7946190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of continuous veno-venous hemofiltration or direct hemoperfusion with polymyxin B-immobilized fiber on neutrophil respiratory oxidative burst in patients with sepsis and septic shock.
    Naka T; Shinozaki M; Akizawa T; Shima Y; Takaesu H; Nasu H
    Ther Apher Dial; 2006 Feb; 10(1):7-11. PubMed ID: 16556130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock.
    Neugebauer EA
    Crit Care Med; 2007 Dec; 35(12):2855-6. PubMed ID: 18043203
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of hemoperfusion with an immobilized polymyxin-B fiber column on cytokine plasma levels in patients with abdominal sepsis.
    Zagli G; Bonizzoli M; Spina R; Cianchi G; Pasquini A; Anichini V; Matano S; Tarantini F; Di Filippo A; Maggi E; Peris A
    Minerva Anestesiol; 2010 Jun; 76(6):405-12. PubMed ID: 20473253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drotrecogin alfa: a second look. More clinical trials in severe sepsis: mostly negative results.
    Prescrire Int; 2007 Feb; 16(87):7-9. PubMed ID: 17323514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early induction of PMX-DHP improves oxygenation in severe sepsis patients with acute lung injury.
    Suyama H; Kawasaki Y; Morikawa S; Kaneko K; Yamanoue T
    Hiroshima J Med Sci; 2008 Dec; 57(3-4):79-84. PubMed ID: 19260559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemoperfusion using polymyxin B-immobilized fibers on non-shock rat sepsis model.
    Iba T; Okamoto K; Kawasaki S; Nakarai E; Miyasho T
    J Surg Res; 2011 Dec; 171(2):755-61. PubMed ID: 20655065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe sepsis and septic shock in pregnancy.
    Barton JR; Sibai BM
    Obstet Gynecol; 2012 Sep; 120(3):689-706. PubMed ID: 22914482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early biomarker activity in severe sepsis and septic shock and a contemporary review of immunotherapy trials: not a time to give up, but to give it earlier.
    Rivers EP; Jaehne AK; Nguyen HB; Papamatheakis DG; Singer D; Yang JJ; Brown S; Klausner H
    Shock; 2013 Feb; 39(2):127-37. PubMed ID: 23324881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New perspectives on immunomodulatory therapy for bacteraemia and sepsis.
    Opal SM
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S70-3. PubMed ID: 21129935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early hemoperfusion with a polymyxin b column improves gastric intramucosal pH in sepsis.
    Kushi H; Miki T; Sakagami Y; Sato J; Saito T; Tanjoh K
    Ther Apher Dial; 2008 Aug; 12(4):278-84. PubMed ID: 18789114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the pathophysiology of the septic host upon admission?
    Giamarellos-Bourboulis EJ
    Int J Antimicrob Agents; 2010 Dec; 36 Suppl 2():S2-5. PubMed ID: 21129934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.